The following information leaflet is available:
Information for Patients (Patient Card) (November 2021)
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Volibris is a registered trademark of Gilead, used under licence by the GlaxoSmithKline Group of Companies.